{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:52:46Z","timestamp":1767865966968,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.imlet.2016.08.012","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T13:36:40Z","timestamp":1473428200000},"page":"131-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Protective effects of agonistic anti-4-1BB antibody on the development of imiquimod-induced psoriasis-like dermatitis in mice"],"prefix":"10.1016","volume":"178","author":[{"given":"Jung Ki","family":"Yoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Kug","family":"Choo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Hoon","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Yeon","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2016.08.012_bib0005","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jaut.2009.12.001","article-title":"Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis","volume":"34","author":"Chandran","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imlet.2016.08.012_bib0010","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2016.08.012_bib0015","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/cmi.2012.15","article-title":"New insights of T cells in the pathogenesis of psoriasis","volume":"9","author":"Cai","year":"2012","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.imlet.2016.08.012_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2004.02310.x","article-title":"Immunopathogenic mechanisms in psoriasis","volume":"135","author":"Gudjonsson","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2016.08.012_bib0025","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1189\/jlb.0212101","article-title":"Targeting the Th17 pathway in psoriasis","volume":"92","author":"Elloso","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.imlet.2016.08.012_bib0030","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/jid.2009.399","article-title":"Circulating Th17 Th22, and Th1 cells are increased in psoriasis","volume":"130","author":"Kagami","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.imlet.2016.08.012_bib0035","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","article-title":"Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation","volume":"174","author":"Sugiyama","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2016.08.012_bib0040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nri2526","article-title":"The role of TNF superfamily members in T-cell function and diseases","volume":"9","author":"Croft","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2016.08.012_bib0045","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.it.2005.06.003","article-title":"Interfacing T-cell effector and regulatory function through CD137 (4-1BB) co-stimulation","volume":"26","author":"Myers","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.imlet.2016.08.012_bib0050","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1002\/ijc.28943","article-title":"Agonistic anti- CD137 antibody treatment leads to antitumor response in mice with liver cancer","volume":"135","author":"Gauttier","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.imlet.2016.08.012_bib0055","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1172\/JCI23792","article-title":"CD137- mediated immunotherapy for allergic asthma","volume":"116","author":"Polte","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2016.08.012_bib0060","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.4049\/jimmunol.168.3.1457","article-title":"Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis","volume":"168","author":"Sun","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2016.08.012_bib0065","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0896-8411(03)00112-4","article-title":"Anti-4-1BB-based immunotherapy for autoimmune diabetes: lessons from a transgenic non-obese diabetic (NOD) model","volume":"21","author":"Sytwu","year":"2003","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imlet.2016.08.012_bib0070","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.4049\/jimmunol.1002681","article-title":"4-1BB triggering ameliorates experimental autoimmune encephalomyelitis by modulating the balance between Th17 and regulatory T cells","volume":"187","author":"Kim","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2016.08.012_bib0075","first-page":"597","article-title":"IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation","volume":"118","author":"Ma","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2016.08.012_bib0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.imlet.2013.01.014","article-title":"Regulatory T cells in atherosclerosis and strategies to induce the endogenous atheroprotective immune response","volume":"151","author":"Chistiakov","year":"2013","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imlet.2016.08.012_bib0085","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL- 17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2016.08.012_bib0090","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1002\/eji.201343801","article-title":"TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis","volume":"43","author":"Flutter","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2016.08.012_bib0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2015.03.010","article-title":"Therapeutic and immunomodulatory effects of glucosamine in combination with low-dose cyclosporine a in a murine model of imiquimod-induced psoriasis","volume":"756","author":"Kim","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.imlet.2016.08.012_bib0100","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/exd.12649","article-title":"Osteopontin deficiency affects imiquimod-induced psoriasis-like murine skin inflammation and lymphocyte distribution in skin, draining lymph nodes and spleen","volume":"24","author":"Frenzel","year":"2015","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.imlet.2016.08.012_bib0105","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nm0402-343","article-title":"Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB","volume":"8","author":"Ye","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2016.08.012_bib0110","doi-asserted-by":"crossref","first-page":"814","DOI":"10.4049\/jimmunol.177.2.814","article-title":"Inhibition of Th2- mediated allergic airway inflammatory disease by CD137 costimulation","volume":"177","author":"Sun","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2016.08.012_bib0115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2567.2004.01952.x","article-title":"Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistance","volume":"113","author":"Foell","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.imlet.2016.08.012_bib0120","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/j.1365-2222.2007.02785.x","article-title":"CD137 ligand prevents the development of T-helper type 2 cell-mediated allergic asthma by interferon-gamma- producing CD8+ T cells","volume":"37","author":"Polte","year":"2007","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.imlet.2016.08.012_bib0125","doi-asserted-by":"crossref","first-page":"18246","DOI":"10.1523\/JNEUROSCI.2473-12.2012","article-title":"Development of experimental autoimmune encephalomyelitis critically depends on CD137 ligand signaling","volume":"32","author":"Mart\u00ednez G\u00f3mez","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.imlet.2016.08.012_bib0130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-pathol-011811-132448","article-title":"Psoriasis","volume":"7","author":"Perera","year":"2012","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.imlet.2016.08.012_bib0135","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/1346-8138.12367","article-title":"Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod","volume":"41","author":"Ueyama","year":"2014","journal-title":"J. Dermatol."},{"key":"10.1016\/j.imlet.2016.08.012_bib0140","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.imlet.2005.06.001","article-title":"Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease","volume":"101","author":"Lee","year":"2005","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imlet.2016.08.012_bib0145","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cyto.2006.04.008","article-title":"4-1BB-mediated amelioration of experimental autoimmune uveoretinitis is caused by indoleamine 2,3-dioxygenase- dependent mechanisms","volume":"34","author":"Choi","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.imlet.2016.08.012_bib0150","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2016.08.012_bib0155","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1177\/147323001204000323","article-title":"4-1BB ligand- mediated imbalance of helper 17T cells and regulatory T cells in patients with allergic asthma","volume":"40","author":"Ai","year":"2012","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.imlet.2016.08.012_bib0160","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2016.08.012_bib0165","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","article-title":"Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation","volume":"174","author":"Sugiyama","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2016.08.012_bib0170","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000170384","article-title":"Regulatory T cells participate in 4-1BB-mediated suppression of experimental allergic conjunctivitis","volume":"148","author":"Sumi","year":"2009","journal-title":"Int. Arch. Allergy Immunol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247816301559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247816301559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T05:49:53Z","timestamp":1568353793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247816301559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":34,"alternative-id":["S0165247816301559"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2016.08.012","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effects of agonistic anti-4-1BB antibody on the development of imiquimod-induced psoriasis-like dermatitis in mice","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2016.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}